Chevy Chase Trust
GNOM icon

Chevy Chase Trust’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Chevy Chase Trust’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,480
Closed -$515K – 655
2021
Q4 		$515K Buy
+6,480
New +$544K ﹤0.01% 617

Other funds holding GNOM

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Chevy Chase Trust's GNOM Position: Q1 2022 in Review

Chevy Chase Trust sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2022, closing a stake of 6,480 shares — an estimated $515K sold.

Chevy Chase Trust first reported a position in GNOM in Q4 2021 and held it in 1 quarter. The position peaked at $515K in Q4 2021. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2022.

  • Chevy Chase Trust reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
  • Chevy Chase Trust sold 6,480 Global X Genomics & Biotechnology ETF shares in Q1 2022, an estimated $515K.
  • Chevy Chase Trust first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and held it in 1 quarter.
  • Chevy Chase Trust's Global X Genomics & Biotechnology ETF position peaked at $515K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2022.

Based on Chevy Chase Trust's 13F filing for Q1 2022, filed 27 Apr 2022.